Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Keros Therapeutics, Inc.Listing on record | Sell | $40.6M | SEC | ||
Keros Therapeutics, Inc.Listing on record | Sell | $2.8M | SEC | ||
Keros Therapeutics, Inc.Listing on record | Sell | $19.9M | SEC | ||
Keros Therapeutics, Inc.Listing on record | Sell | $21.8M | SEC | ||
Keros Therapeutics, Inc.Listing on record | Buy | $648.3K | conv 35ClusterFirst in 12mo | SEC | |
Keros Therapeutics, Inc.Listing on record | Buy | $300K | conv 37ClusterFirst in 12mo | SEC | |
Keros Therapeutics, Inc.Listing on record | Buy | $1.3M | conv 35ClusterFirst in 12mo | SEC | |
Keros Therapeutics, Inc.Listing on record | Buy | $720K | conv 35ClusterFirst in 12mo | SEC |